Centene Corporation Reports 2010 Fourth Quarter and Full Year Earnings

ST. LOUIS, Feb. 8, 2011 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter and year ended December 31, 2010.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

   
                 
 

2010 Highlights

   
   

Q4

   

Full Year

     
 

Premium and Service Revenues (in millions)

$

1,129.5

   

$

4,283.8

     
 

Consolidated HBR

 

83.3

%

   

83.8

%

   
 

General & Administrative expense ratio

 

13.0

%

   

12.8

%

   
 

Diluted EPS

$

0.50

   

$

1.80

     
 

Cash flow from operations (in millions)

$

194.6

   

$

168.9

     
                     
   
                   

 

Fourth Quarter Highlights

  • Quarter-end managed care at-risk membership of 1,533,500, an increase of 75,300 members, or 5.2% year over year.
  • Premium and Service Revenues of $1,129.5 million, representing 7.5% year over year growth.
  • Health Benefits Ratio of 83.3%, compared to 83.9% in the prior year.  
  • General and Administrative expense ratio of 13.0%, compared to 12.7% in the prior year.
  • Cash flow from operations of $194.6 million.
  • Days in claims payable of 45.6.
  • Diluted earnings per share from continuing operations of $0.50 (which includes the dilution from the stock offering in early 2010), compared to $0.53 in the prior year.
  • Debt to capitalization of 29.3%, or 23.9% excluding the $80.0 million non-recourse mortgage note.

 

Other Events

 

  • During the fourth quarter of 2010, we completed the conversion of approximately 22,500 Florida members from Access Health Solutions LLC to our subsidiary, Sunshine State Health Plan, on an at-risk basis.  Additionally, in December 2010, we completed the acquisition of Citrus Health Care, Inc., a Florida Medicaid and Long-term Care health plan.  We served 194,900 at-risk members in Florida as of December 31, 2010.
  • In December 2010, we refinanced the construction loan related to our corporate headquarters development with an $80 million non-recourse mortgage loan. In January 2011, we refinanced our $300 million Revolving Credit Facility with a new $350 million unsecured Revolving Credit Facility.
  • In December 2010, Cenpatico Behavioral Health of Arizona began operating under an expanded contract to manage behavioral healthcare services in an additional four counties.  
  • In December 2010, one of our highly regarded health programs, Start Smart for Your Baby, was the recipient of the URAC/GKEN International Health Promotion Award for Community Health.   Start Smart for Your Baby also received a gold award at the 2010 Web Health Awards for its audio book and a merit award for its podcasts.
  • In January 2011, Magnolia Health Plan began operating under a new contract in Mississippi to provide managed care services to Medicaid recipients through the Mississippi Coordinated Access Network (MississippiCAN) Program.  
  • In January 2011, we entered into an agreement with Pima Health Systems in Arizona to administer their long-term care program on a non-risk basis.
  • In February 2011, Superior HealthPlan began operating under an additional STAR+PLUS ABD contract in Texas in the Dallas service area.

 

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "Our team's coordinated and consistent efforts produced solid financial and operational performance in 2010, setting the stage for continued success in 2011."

 

The following table depicts membership in Centene's managed care organizations, by state, at December 31, 2010 and 2009:

   
   

December 31,

 
   

2010

 

2009

 

Arizona

 

22,400

 

20,700

 

Florida

 

194,900

 

102,600

 

Georgia

 

305,800

 

309,700

 

Indiana

 

215,800

 

208,100

 

Massachusetts

 

36,200

 

27,800

 

Ohio

 

160,100

 

150,800

 

South Carolina

 

90,300

 

48,600

 

Texas

 

433,100

 

455,100

 

Wisconsin

 

74,900

 

134,800

 

Total at-risk membership

 

1,533,500

 

1,458,200

 

Non-risk membership

 

4,200

 

63,700

 

Total

 

1,537,700

 

1,521,900

 
           
   
         

 

The following table depicts membership in Centene's managed care organizations, by member category, at December 31, 2010 and 2009:

   
   

December 31,

 
   

2010

 

2009

 

Medicaid

 

1,177,100

 

1,081,400

 

CHIP & Foster Care

 

210,500

 

263,600

 

ABD & Medicare

 

104,600

 

82,800

 

Hybrid Programs

 

36,200

 

27,800

 

Long-term Care

 

5,100

 

2,600

 

Total at-risk membership

 

1,533,500

 

1,458,200

 

Non-risk membership

 

4,200

 

63,700

 

Total

 

1,537,700

 

1,521,900

 
   
         

 

Statement of Operations: Three Months Ended December 31, 2010

  • For the fourth quarter of 2010, Premium and Service Revenues increased 7.5% to $1,129.5 million from $1,050.8 million in the fourth quarter of 2009.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases in 2010.  This increase was moderated by the removal of pharmacy service in two states in 2010.  These pharmacy carve outs had the effect of reducing 2010 fourth quarter revenue by approximately $52 million.
  • Consolidated HBR of 83.3% for the fourth quarter of 2010 represents a decrease of 0.6% from the comparable period in 2009.  The year over year improvement in HBR is due to rate increases, decreased costs associated with the flu and better performance in our Florida health plan.  Consolidated HBR decreased 0.9% sequentially from the third quarter of 2010.  The improvement in HBR was due to the impact of rate increases in several markets and improvements in our Florida health plan.
  • Consolidated G&A expense as a percent of premium and service revenues was 13.0% in the fourth quarter of 2010, an increase from 12.7% in the fourth quarter of 2009.  The increase in the G&A ratio between years reflects increased business expansion costs, including Mississippi, Dallas STAR+PLUS and Illinois.  
  • Earnings from continuing operations increased to $45.5 million in 2010 from $37.8 million in 2009, or 20.4% year over year.  Net earnings from continuing operations were $25.5 million, or $0.50 per diluted share in 2010 (which includes the dilution from the stock offering in early 2010), compared to $23.7 million, or $0.53 per diluted share in the fourth quarter of 2009.  

 

Statement of Operations: Year Ended December 31, 2010

 

  • For the year ended December 31, 2010, Premium and Service Revenues increased 10.5% to $4.3 billion in 2010 from $3.9 billion in 2009.  This reflects a 13.6% increase in member months, offset by reduced revenue of $185 million as a result of pharmacy carve outs in 2010.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases in 2010.  
  • The consolidated HBR of 83.8% for 2010 represented a 0.3% increase from the 2009 consolidated HBR of 83.5%.  The increase is primarily due to the growth in our Florida health plan where we have experienced a higher HBR.  
  • G&A expenses as a percent of Premium and Service Revenues decreased to 12.8% in 2010, compared to 13.3% in 2009.  The decrease primarily reflects the leveraging of our expenses over higher revenues, partially offset by increased business expansion costs.
  • Earnings from continuing operations increased to $157.1 million in 2010 from $138.1 million in 2009, or 13.7% year over year.  Net earnings from continuing operations were $90.9 million, or $1.80 per diluted share in 2010 (which includes the dilution from the stock offering in early 2010), compared to $86.1 million, or $1.94 per diluted share in 2009.  

 

Balance Sheet and Cash Flow

 

At December 31, 2010, the Company had cash and investments of $1,073.9 million, including $1,043.0 million held by its regulated entities and $30.9 million held by its unregulated entities.  Medical claims liabilities totaled $456.8 million, representing 45.6 days in claims payable.  Total debt was $330.6 million and debt to capitalization was 29.3%.  Excluding the $80.0 million non-recourse mortgage note, our debt to capital ratio is 23.9%.  Full year 2010 cash flow from operations was $168.9 million, or 1.7 times net earnings.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

   

Days in claims payable, September 30, 2010

47.1

   

  Reduced time of claims processing and payment

(1.4)

   

  Other

(0.1)

   

Days in claims payable, December 31, 2010

45.6

   
   
   
     

 

During the fourth quarter of 2010, we experienced increased electronic claims submissions and auto-adjudication of claims which reduced the average time from claims incurred to claims paid by 1.4 days, which is reflected in the decrease in period end claims inventory from the third quarter as presented in Supplemental Financial Data included in this release.  We expect our days in claims payable to be within our targeted range of 43 to 48 days in 2011.  This may be higher from time to time as we have new plans begin operations.  

Outlook

The table below depicts the Company's annual guidance from continuing operations for 2011:

   
   

Full Year 2011

   
   

Low

 

High 

   

Premium and Service Revenues (in millions)

 

$   4,900

 

$  5,100

   

Diluted EPS

 

$    2.00

 

$  2.10

   

Consolidated HBR

 

84.0%

 

85.0%

   

General & Administrative expense ratio

 

12.0%

 

12.5%

   
             

Diluted Shares Outstanding (in thousands)

 

51,500

   
             
   
           

 

Conference Call

As previously announced, the Company will host a conference call Tuesday, February 8, 2011, at 8:30 A.M. (Eastern Time) to review the financial results for the fourth quarter ended December 31, 2010, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  Investors and other interested parties are invited to listen to the conference call by dialing 1-877-887-1134 in the U.S. and Canada; 1-412-317-0794 from abroad, or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months until 11:59 PM (Eastern Time) on Tuesday, February 7, 2012, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, February 16, 2011, by dialing 1-877-344-7529 the U.S. and Canada, or 1-412-317-0088 from abroad, and entering access code 447292.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

(Tables Follow)





 
 

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 
   

December 31, 

2010

 

December 31,

2009

   

ASSETS

             

Current assets:

             

Cash and cash equivalents of continuing operations

 

$

433,914

$

400,951

   

Cash and cash equivalents of discontinued operations

   

252

 

2,801

   

Total cash and cash equivalents

   

434,166

 

403,752

   

Premium and related receivables, net of allowance for uncollectible accounts of $17 and $1,338, respectively

   

136,243

 

103,456

   

Short-term investments, at fair value (amortized cost $21,141 and $39,230, respectively)

   

21,346

 

39,554

   

Other current assets

   

64,154

 

64,866

   

Current assets of discontinued operations other than cash

   

912

 

4,506

   

Total current assets

   

656,821

 

616,134

   

Long-term investments, at fair value (amortized cost $585,862 and $514,256, respectively)

   

595,879

 

525,497

   

Restricted deposits, at fair value (amortized cost $22,755 and $20,048, respectively)

   

22,758

 

20,132

   

Property, software and equipment, net of accumulated depreciation of $138,629 and $103,883, respectively

   

326,341

 

230,421

   

Goodwill

   

278,051

 

224,587

   

Intangible assets, net

   

29,109

 

22,479

   

Other long-term assets

   

30,057

 

36,829

   

Long-term assets of discontinued operations

   

4,866

 

26,285

   

Total assets

 

$

1,943,882

$

1,702,364

   
 

LIABILITIES AND STOCKHOLDERS' EQUITY

             

Current liabilities:

             

Medical claims liability

 

$

456,765

$

470,932

   

Accounts payable and accrued expenses

   

185,218

 

132,001

   

Unearned revenue

   

117,344

 

91,644

   

Current portion of long-term debt

   

2,817

 

646

   

Current liabilities of discontinued operations

   

3,102

 

20,685

   

Total current liabilities

   

765,246

 

715,908

   

Long-term debt

   

327,824

 

307,085

   

Other long-term liabilities

   

53,378

 

59,561

   

Long-term liabilities of discontinued operations

   

379

 

383

   

Total liabilities

   

1,146,827

 

1,082,937

   
               

Commitments and contingencies

             
               

Stockholders' equity:

             

Common stock, $.001 par value; authorized 100,000,000 shares; and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010, and 45,593,383 issued and 43,179,373 outstanding shares at December 31, 2009

   

52

 

46

   

Additional paid-in capital

   

384,206

 

281,806

   

Accumulated other comprehensive income:

             

Unrealized gain on investments, net of tax

   

6,424

 

7,348

   

Retained earnings

   

453,743

 

358,907

   

Treasury stock, at cost (2,555,213 and 2,414,010 shares, respectively)

   

(50,486)

 

(47,262)

   

Total Centene stockholders' equity

   

793,939

 

600,845

   

Noncontrolling interest

   

3,116

 

18,582

   

Total stockholders' equity

   

797,055

 

619,427

   

Total liabilities and stockholders' equity

 

$

1,943,882

$

1,702,364

   
   
   
             

 
   

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)

 
 

Three Months Ended

December 31,

 

Year Ended

December 31,

   
 

2010

   

2009

 

2010

   

2009

   

Revenues:

                             

Premium

$

1,106,370

   

$

1,031,812

 

$

4,192,172

   

$

3,786,525

   

Service

 

23,118

     

19,018

   

91,661

     

91,758

   

Premium and service revenues

 

1,129,488

     

1,050,830

   

4,283,833

     

3,878,283

   

Premium tax

 

51,481

     

41,896

   

164,490

     

224,581

   

Total revenues

 

1,180,969

     

1,092,726

   

4,448,323

     

4,102,864

   

Expenses:

                             

Medical costs

 

922,070

     

865,415

   

3,514,394

     

3,163,523

   

Cost of services

 

16,414

     

14,425

   

63,919

     

60,789

   

General and administrative expenses

 

146,751

     

133,005

   

547,823

     

514,529

   

Premium tax

 

50,233

     

42,103

   

165,118

     

225,888

   

Total operating expenses

 

1,135,468

     

1,054,948

   

4,291,254

     

3,964,729

   

Earnings from operations

 

45,501

     

37,778

   

157,069

     

138,135

   

Other income (expense):

                             

Investment and other income

 

3,293

     

3,910

   

15,205

     

15,691

   

Interest expense

 

(5,452)

     

(4,108)

   

(17,992)

     

(16,318)

   

Earnings from continuing operations, before income tax expense

 

43,342

     

37,580

   

154,282

     

137,508

   

Income tax expense

 

16,958

     

13,781

   

59,900

     

48,841

   

Earnings from continuing operations, net of income tax expense

 

26,384

     

23,799

   

94,382

     

88,667

   

Discontinued operations, net of income tax expense (benefit)     of $12, $(56), $4,388 and $(1,204), respectively

 

(65)

     

(28)

   

3,889

     

(2,422)

   

Net earnings

 

26,319

     

23,771

   

98,271

     

86,245

   

Noncontrolling interest

 

920

     

56

   

3,435

     

2,574

   

Net earnings attributable to Centene Corporation

$

25,399

   

$

23,715

 

$

94,836

   

$

83,671

   
                               

Amounts attributable to Centene Corporation common shareholders:

                             

Earnings from continuing operations, net of income tax expense

$

25,464

   

$

23,743

 

$

90,947

   

$

86,093

   

Discontinued operations, net of income tax (benefit) expense

 

(65)

     

(28)

   

3,889

     

(2,422)

   

Net earnings

$

25,399

   

$

23,715

 

$

94,836

   

$

83,671

   
                               

Net earnings (loss) per share attributable to Centene Corporation:

                             

Basic:

                             

Continuing operations

$

0.52

   

$

0.55

 

$

1.87

   

$

2.00

   

Discontinued operations

 

     

   

0.08

     

(0.06)

   

Earnings per common share

$

0.52

   

$

0.55

 

$

1.95

   

$

1.94

   

Diluted:

                             

Continuing operations

$

0.50

   

$

0.53

 

$

1.80

   

$

1.94

   

Discontinued operations

 

     

   

0.08

     

(0.05)

   

Earnings per common share

$

0.50

   

$

0.53

 

$

1.88

   

$

1.89

   
                               

Weighted average number of shares outstanding:

                             

Basic

 

49,356,768

     

43,068,502

   

48,754,947

     

43,034,791

   

Diluted

 

51,205,720

     

44,513,679

   

50,447,888

     

44,316,467

   
   
   
                             

 
   

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 
   

Year Ended December 31,

   
   

2010

   

2009

   

Cash flows from operating activities:

                 

Net earnings

 

$

98,271

   

$

86,245

   

Adjustments to reconcile net earnings to net cash provided by operating activities:

                 

Depreciation and amortization

   

52,000

     

44,004

   

Stock compensation expense

   

13,874

     

14,634

   

(Gain) loss on sale of investments, net

   

(6,337)

     

(141)

   

(Gain) on sale of UHP

   

(8,201)

     

   

Impairment loss

   

5,531

     

   

Deferred income taxes

   

10,317

     

3,696

   

Changes in assets and liabilities:

                 

Premium and related receivables

   

(23,359)

     

2,379

   

Other current assets

   

(3,240)

     

(1,263)

   

Other assets

   

(2,028)

     

9

   

Medical claims liability

   

(30,421)

     

79,000

   

Unearned revenue

   

25,700

     

78,345

   

Accounts payable and accrued expenses

   

37,398

     

(60,915)

   

Other operating activities

   

(573)

     

2,202

   

Net cash provided by operating activities

   

168,932

     

248,195

   

Cash flows from investing activities:

                 

Capital expenditures

   

(63,304)

     

(23,721)

   

Capital expenditures of Centene Center LLC

   

(55,252)

     

(59,392)

   

Purchase of investments

   

(615,506)

     

(791,194)

   

Sales and maturities of investments

   

570,423

     

642,783

   

Proceeds from asset sales

   

13,420

     

   

Investments in acquisitions, net of cash acquired, and investment in equity method investee

   

(60,388)

     

(38,563)

   

Net cash used in investing activities

   

(210,607)

     

(270,087)

   

Cash flows from financing activities:

                 

Proceeds from exercise of stock options

   

3,419

     

2,365

   

Proceeds from borrowings

   

218,538

     

659,059

   

Proceeds from stock offering

   

104,534

     

   

Payment of long-term debt

   

(195,728)

     

(616,219)

   

Purchase of noncontrolling interest

   

(48,257)

     

   

Distributions (to) from noncontrolling interest

   

(7,387)

     

8,049

   

Excess tax benefits from stock compensation

   

963

     

53

   

Common stock repurchases

   

(3,224)

     

(6,304)

   

Debt issue costs

   

(769)

     

(458)

   

Net cash provided by financing activities

   

72,089

     

46,545

   

Net increase in cash and cash equivalents

   

30,414

     

24,653

   

Cash and cash equivalents, beginning of period

   

403,752

     

379,099

   

Cash and cash equivalents, end of period

 

$

434,166

   

$

403,752

   
                   

Supplemental disclosures of cash flow information:

                 

Interest paid

 

$

17,296

   

$

15,428

   

Income taxes paid

 

$

53,938

   

$

52,928

   
                   

Supplemental disclosure of non-cash investing and financing activities:

                 

Contribution from noncontrolling interest

 

$

306

   

$

5,875

   

Capital expenditures

 

$

8,720

   

$

(1,476)

   
   
   
                 

 
   

CENTENE CORPORATION

 

CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA

 
 

Q4

 

Q3

 

Q2

 

Q1

 

Q4

 
 

2010

 

2010

 

2010

 

2010

 

2009

 

MEMBERSHIP

                   

Managed Care:

                   

Arizona                           

22,400

 

22,300

 

22,100

 

21,700

 

20,700

 

Florida                            

194,900

 

116,300

 

113,100

 

105,900

 

102,600

 

Georgia                           

305,800

 

300,900

 

295,600

 

301,000

 

309,700

 

Indiana                            

215,800

 

213,300

 

212,700

 

211,400

 

208,100

 

Massachusetts                     

36,200

 

34,400

 

30,100

 

26,900

 

27,800

 

Ohio                              

160,100

 

161,800

 

159,300

 

156,000

 

150,800

 

South Carolina                      

90,300

 

90,600

 

92,600

 

53,900

 

48,600

 

Texas                             

433,100

 

428,100

 

475,500

 

459,600

 

455,100

 

Wisconsin                         

74,900

 

106,100

 

133,600

 

134,900

 

134,800

 

Total at-risk membership        

1,533,500

 

1,473,800

 

1,534,600

 

1,471,300

 

1,458,200

 

Non-risk membership                 

4,200

 

35,900

 

50,900

 

62,200

 

63,700

 

TOTAL                     

1,537,700

 

1,509,700

 

1,585,500

 

1,533,500

 

1,521,900

 
                     

Medicaid                           

1,177,100

 

1,122,800

 

1,135,500

 

1,088,300

 

1,081,400

 

CHIP & Foster Care                  

210,500

 

219,100

 

272,400

 

266,300

 

263,600

 

ABD & Medicare                     

104,600

 

94,500

 

93,800

 

87,100

 

82,800

 

Hybrid Programs                    

36,200

 

34,400

 

30,100

 

26,900

 

27,800

 

Long-term Care                     

5,100

 

3,000

 

2,800

 

2,700

 

2,600

 

Total at-risk membership        

1,533,500

 

1,473,800

 

1,534,600

 

1,471,300

 

1,458,200

 

Non-risk membership                 

4,200

 

35,900

 

50,900

 

62,200

 

63,700

 

TOTAL                     

1,537,700

 

1,509,700

 

1,585,500

 

1,533,500

 

1,521,900

 
                     

Specialty Services (a):

                   

Cenpatico Behavioral Health

                   

Arizona                           

174,600

 

121,300

 

119,700

 

119,300

 

120,100

 

Kansas                           

39,200

 

39,800

 

39,100

 

39,800

 

41,400

 

TOTAL                     

213,800

 

161,100

 

158,800

 

159,100

 

161,500

 
                     

(a) Includes external membership only.

                 
                     

REVENUE PER MEMBER PER MONTH (b)

$

239.66

 

$

224.62

 

$

218.40

 

$

219.90(c)

 

$

233.66

 
                     

CLAIMS(b)

                   

Period-end inventory                 

434,900

 

469,000

 

480,400

 

341,400

 

423,400

 

Average inventory                  

304,700

 

307,500

 

306,900

 

283,900

 

279,000

 

Period-end inventory per member       

0.28

 

0.32

 

0.31

 

0.23

 

0.29

 

(b) Revenue per member and claims information are presented for the Managed Care at-risk members.

 

(c) Reduction in revenue per member per month is a result of the pharmacy carve-outs in 2010.

 
   
   
                             

 
   
   
 

Q4

 

Q3

 

Q2

 

Q1

 

Q4

 
 

2010

 

2010

 

2010

 

2010

 

2009

 
                     

DAYS IN CLAIMS PAYABLE

                   

Medical                           

44.5

 

46.0

 

47.2

 

46.6

 

48.1

 

Pharmacy                         

1.1

 

1.1

 

1.0

 

1.1

 

2.0

 

TOTAL                     

45.6

 

47.1

 

48.2

 

47.7

 

50.1

 

Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

 
                     

CASH AND INVESTMENTS (in millions)

                 

Regulated                         

$

1,043.0

 

$

895.4

 

$

813.0

 

$

917.9

 

$

949.9

 

Unregulated                        

 

30.9

   

32.7

   

39.4

   

51.3

   

36.2

 

TOTAL                     

$

1,073.9

 

$

928.1

 

$

852.4

 

$

969.2

 

$

986.1

 
                     

DEBT TO CAPITALIZATION

29.3%

 

24.7%

 

24.5%

 

23.7%

 

33.2%

 

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT (d)

23.9%

                 

Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  

(d) The non-recourse debt represents our mortgage note payable of $80.0 million at December 31, 2010.

 
   
   
                             

 
   

Operating Ratios:

 
 

Three Months Ended

December 31,

 

Year Ended

December 31,

 
 

2010

   

2009

 

2010

   

2009

 

Health Benefits Ratios:

                           

     Medicaid and CHIP

82.4

%

   

85.3

%

 

83.6

%

   

84.6

%

 

    ABD and Medicare

86.8

     

79.9

   

85.0

     

81.1

   

    Specialty Services

83.4

     

81.8

   

83.4

     

80.2

   

        Total

83.3

     

83.9

   

83.8

     

83.5

   
                             

Total General & Administrative Expense Ratio

13.0

%

   

12.7

%

 

12.8

%

   

13.3

%

 
   
   
                           

 
   

MEDICAL CLAIMS LIABILITY (In thousands)

 

The changes in medical claims liability are summarized as follows:

 
   

Balance, December 31, 2009

$

470,932

   

Incurred related to:

       

Current period

 

3,582,463

   

Prior period

 

(68,069)

   

Total incurred

 

3,514,394

   

Paid related to:

       

Current period

 

3,133,527

   

Prior period

 

395,034

   

Total paid

 

3,528,561

   

Balance, December 31, 2010

$

456,765

   
   
   
       

 

Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to:  Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to December 31, 2009.

SOURCE Centene Corporation